Empogaduo Tablet 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)

Adult dose

The recommended dosage of this medication is 1 tablet once, twice a day. It should be taken with meals. Patients who cannot achieve adequate blood sugar control with metformin alone or in combination with insulin or other medications should take 5 mg of empagliflozin twice daily (total daily dose of 10 mg) alongside their current dosage of metformin. When tolerance for empagliflozin 10 mg (total daily dose) is good, additional

This medication is used to help control blood sugar in patients with diabetes. However, during use, there is a risk of rare complications such as severe lactic acidosis that require attention. Additionally, when taken with insulin or other antidiabetic medications, hypoglycemia may occur, so symptoms should be closely observed. This medication should not be administered to patients with moderate to severe renal impairment or acute kidney injury. Caution is also advised in conditions such as acute infections, heart failure, acute myocardial infarction, or sepsis. It is also safest for women who are pregnant or may become pregnant, as well as breastfeeding mothers, to avoid using this medication. During treatment, regular kidney function tests and careful observation of fluid status are necessary. If dehydration symptoms such as diarrhea or vomiting occur, immediate consultation with a doctor is required. Urinary or genital infections may occur, and prompt treatment should be sought if symptoms arise. This medication may lower vitamin B12 levels, necessitating regular blood tests. If surgery or tests using iodinated contrast agents are to be performed, this medication should be discontinued for a certain period, and treatment can be restarted only after confirming normal kidney function. Alcohol consumption may increase the risk of lactic acidosis, so caution should be exercised to avoid excessive drinking during therapy. Elderly patients or those at risk for fluid loss should be managed more carefully while using this medication. Any symptoms of hypoglycemia, lactic acidosis, or ketoacidosis that occur during treatment should be immediately reported to healthcare providers. Finally, its safety and efficacy have not been established in children, so its use is not recommended.

Serious side effects

Urticaria, angioedema, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, peeling skin, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory distress accompanied by cough + fever, skin or eyes turning yellow (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances,

Mild side effects

• Hypoglycemia
• urinary tract infection
• genital infection
• increased urination
• nausea
• vomiting
• diarrhea
• abdominal pain
• loss of appetite
• constipation

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature.

Appearance

Light brownish purple, oval film-coated tablet with a convex shape on both sides

Package unit

Inner use - 60 tablets/bottle, Inner use - 30 tablets/bottle, Inner use - 10 tablets/box [(10 tablets/PTP x 1)], Inner use - 60 tablets/box [(10 tablets/PTP x 6)]